Bayer's 2006 income climbs 5.4%

19 March 2007

German drugmaker Bayer AG says that its net income, for the fourth quarter of 2006, was 311.0 million euros ($410.8 million), or 41 cents per share, up from the 46.0 million euros, or 6 cents per share, it earned in the comparable period in 2005. This was ahead of the average esimate of analysts surveyed by Bloomberg News. The firm said that the rise in its profits in the period had been driven by a 25% increase in sales to 7.97 billion euros in the final three months of 2006. For the full year, Bayer's net income was 1.68 billion euros, up 5.4%, while sales increased 17.2% to 28.95 billion euros. Chairman of the Leverkusen-headquartered company's board, Werner Wenning, predicted further improvement in the firm's earning power in 2007, citing the opportunities presented by the acquisition of Schering AG.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight